Analysis: Investment in biotech startups continues

10/9/2007 | Financial Times (free content)

With Big Pharma showing an interest in acquiring biotech startups to boost their pipelines amid upcoming patent expirations, venture capital backers are investing heavily in the startup biotech sector. However, if prices continue to rise for early-stage, risky products, partnerships may again become the preferred route to accessing new drugs for major drugmakers, this Financial Times analysis says.

View Full Article in:

Financial Times (free content)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Clara, CA
Senior Officer, Drugs and Medical Devices
The Pew Charitable Trusts
Washington, DC
Chief Financial Officer
B. E. Smith
Miramar, FL
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA